Life Sciences

The pair will integrate real-time diagnostic data into marketing workflows, with the aim of helping pharmaceutical companies target clinicians at treatment decision moments.

The funds will be used for further product innovation and to scale the company's reach.

AI can streamline workflows across health systems, but Greg O'Neill, ChristianaCare's director of patient education, says the technology misses its purpose if the information it provides to patients and families isn't useful.

The platform offers AI models and agents that help scientists design, test and iterate experiments to identify and analyze potential antibody therapies.

The company's agentic platform works to help pharmaceutical companies turn data into automated analyses, strategic insights and commercialization tools.

The pharma giant will deploy OpenAI's most advanced capabilities across its global operations, from drug discovery to commercial functions, and upskill its workforce in AI literacy.

Also, 4DMedical has raised $57 million and obtained clearance to expand across Europe.

The deal grants Lilly exclusive global rights to use Insilico's Pharma.AI platform for drug discovery and development across multiple therapeutic areas.

Ellipsis Health partners with PromptWell to boost enrollment in patient care programs, while CaryHealth teams up with HealthDyne to enhance medication management.

The company will use the funds to enhance its platform, grow its workforce and expand partnerships with health systems to automate medication approval workflows.